CBD Related Content

Hannah Deacon, co-founder of Maple Tree Consultancy, explores how COVID is elevating and shaping the medical application of CBD.

Here, Lifescience Legal Design discuss the legal status of CBD and hemp in the European Union.

Savage Cabbage Ltd offer their expertise to explain what cannabidiol (CBD) is and how it works: Read on to find out their perspective.

Associate, David Hardstaff and Partner, John Binns at BCL Solicitors LLP, explain here how cannabis wonder child takes a knock in light of the European Commission’s ‘pause’ on CBD novel food applications mean for this booming industry.

Lorraine Clark, Director of hapihemp, explores whether CBD oil can be used to restore hormonal imbalances.

The July 2020 edition of North America Analysis covers a range of policy topics from the region, including comment from the UN’s Under-Secretary-General for Humanitarian Affairs, Mark Lowcock about the importance of anticipatory action when it comes to humanitarian affairs.

Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.

Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.

Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.

Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, discusses new funding opportunities for cannabinoid research.

Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.

In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.

In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.

Elixinol has launched a new UK range of blended, full-spectrum CBD capsules using six original combinations developed to support good health and wellbeing.

Kathleen Denoodt shares with us what we need to know about the export of medicinal cannabis from Israel.

In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.

Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.

Here, OilsBySimpson explains the findings of a new study on 400 patients prescribed cannabidiol (CBD). The results show promise for pain, anxiety, and depression.